Citations

Clear

9383 citation(s) found for "Thomas, PS".

Inter-atrial Septal Balloon Dilation to Facilitate Intracardiac Echocardiography Guided Left Atrial Appendage Occlusion
Goyal, Sandeep , Bhimani, Ashish A. , Kella, Danesh , Tyagi, Anahita , Polsani, Venkateshwar , Deering, Thomas F. , Kella, Danesh K , Goyal, Sandeep K

Mayo Clinic

No container title available | March 10, 2024 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.22541/au.171004751.17002918/v1 Get It

Background: Percutaneous left atrial appendage occlusion (LAAO) is traditionally performed under general anesthesia with trans-esophageal echocardiography guidance. Intracardiac echo (ICE) guided LAAO closure is increasing in clinical use. The ICE catheter is crossed into LA via interatrial septum (IAS) after the septum is dilated with LAAO delivery sheath. This step can be time-consuming and requires significant ICE catheter manipulation increasing the risk of cardiac perforation. Pre-emptive septal balloon dilation can potentially help with the advancement of ICE in LA. Objective: Evaluate the effect of pre-dilation of IAS with an 8 mm balloon on ease of crossing the ICE catheter, fluoroscopy time for crossing, and overall procedure time. Methods: The Piedmont LAAO registry was used to identify consecutive patients undergoing LAAO. The initial 25 patients where balloon dilation of IAS was performed served as the experimental cohort, and the 25 consecutive patients prior to that in whom balloon dilation was not performed, served as controls. For the experimental group, after a trans-septal puncture, the sheath was retracted to the right atrium with guide wire still in the LA. An 8x40 mm Evercoss™ over the wire balloon was inflated across the IAS. The ICE catheter was then crossed into the LA using the fluoroscopic landmark of the guide wire and the ICE imaging. The sheath was then advanced along the ICE catheter via the transseptal puncture (TSP) and the procedure continued. Follow up CT imaging was obtained in 4-8 weeks. Results: Each group included 25 patients. There were no significant differences in baseline characteristics. All procedures were performed successfully with the use of conscious sedation and ICE guidance. There was a significant reduction in overall procedure time, fluoroscopy time, and time for trans-septal puncture to ICE in LA. There was no difference in the size of the acute residual interatrial shunt as measured via ICE or size and presence of iatrogenic ASD at follow up. Conclusion: Balloon dilation of TSP is safe and associated with increased efficiencies in ICE guided LAAO procedures.
The natural history of aneurysms incompletely occluded by placement of a flow diverter: a multiinstitutional study
Theiss, Peter , Ali, Ahmed Essam, McGuire, Laura Stone , Brinjikji, Waleed , Naamani, Kareem El, Amllay, Abdelaziz , Tjoumakaris, Stavropoula , Jabbour, Pascal , Salem, Mohamed M. , Burkhardt, Jan‐Karl , Jankowitz, Brian T. , Abla, Adib A. , Kan, Peter , Alaraj, Ali , Alaraj, Ali , Abla, Adib , Burkhardt, Jan‐Karl , Lanzino, Giuseppe , Ghozy, Sherief , Naamani, Kareem El , Jabbour, Pascal , Tonetti, Daniel A. , Robledo, Ariadna

Mayo Clinic

Journal of Neurosurgery | March 8, 2024 | Volume: 141 | Issue: 2 | Pages: 310-315

10.3171/2023.12.jns232221 | PMID 38457799 Get It

OBJECTIVE Treatment of intracranial aneurysms by flow diversion is safe and effective and is increasingly popular. However, the correct treatment paradigm for aneurysms incompletely treated by initial placement of a flow diverter has not been established, nor have the subsequent natural history and occlusion rates of such aneurysms. The authors sought to outline the natural history of such aneurysms, which to date have been considered partially treated. METHODS The authors retrospectively reviewed consecutive cases from 6 high-volume neurointerventional services, including all cases in which the first follow-up imaging after placement of a flow diverter showed incomplete occlusion of the aneurysm, and for which subsequent clinical and/or radiological follow-up was available. All included patients were treated with the Pipeline Flex embolization device or the Pipeline Flex embolization device with Shield Technology. Subsequent radiographic and clinical outcome data were collected and analyzed using the Kaplan-Meier survival function. RESULTS A total of 263 patients with persistently patent aneurysms on first follow-up imaging after flow diversion were identified. Of these, 204 had clinical follow-up and 152 had additional imaging follow-up. Of this final cohort, 148 aneurysms were unruptured, and 4 were ruptured. The average aneurysm size by maximum dimension was 10.8 mm. The average recorded follow-up was 27.8 months in the cohort, with some patients followed for as long as 9 years from treatment. Over the course of 403 person-years of follow-up, no delayed aneurysm ruptures were recorded. Both with and without retreatment, aneurysms showed a trend toward progressive occlusion over time. Complications related to device placement were low. CONCLUSIONS Aneurysms that have been incompletely treated by flow diversion have a benign natural history with progression toward occlusion over time, with or without retreatment.
IDH-mutant myeloid neoplasms are associated with seronegative rheumatoid arthritis and innate immune activation
Hong, Lih En , Wechalekar, Mihir D. , Small, Annabelle , Lim, Kelly , Thompson-Peach, Chloe , Li, Joule J., Chhetri, Rakchha , Scott, Hamish S. , Brown, Anna , Hahn, Christopher N , Sajid, Salvia , Robinson, Nirmal , Thomas, Ranjeny , Branford, Susan , D’Andrea, Richard J. , Samaraweera, Saumya E. , Patnaik, Mrinal M. , Hiwase, Devendra , Small, Annabelle , Lim, Kelly , Thompson-Peach, Chloe , Scott, Hamish , Brown, Anna L , Hahn, Christopher , Sajid, Salvia , Robinson, Nirmal , Branford, Susan , D'Andrea, Richard J , Samaraweera, Saumya E , Patnaik, Mrinal , Proudman, Susanna , Kok, Chung H , Shah, Mithun V , Hiwase, Devendra , Kutyna, Monika , Yeung, David , THOMAS, DANIEL W. , Kok, Chung Hoow , Shah, Meera

Mayo Clinic

Blood | March 8, 2024 | Volume: 143 | Issue: 18 | Pages: 1873-1877

10.1182/blood.2023023593 | PMID 38457663 Get It

Abstract High prevalence of IDH mutations in seronegative rheumatoid arthritis (RA) with myeloid neoplasm, elevated 2-hydroxyglutarate, dysregulated innate immunity, and proinflammatory microenvironment suggests causative association between IDH mutations and seronegative RA. Our findings merit investigation of IDH inhibitors as therapeutics for seronegative IDH-mutated RA.
Acute pulmonary injury in hematology patients supported with pathogen-reduced and conventional platelet components
Wheeler, Allison P. , Snyder, Edward L. , Refaai, Majed A. , Cohn, Claudia S. , Poisson, Jessica , Fontaine, Magali J. , Sehl, Mary E. , Uhl, Lynne , Fenelus, Maly , Coyle, Thomas, Becker, Joanne , Jeng, Michael , Young, Pampee P. , OʼBrien, Jennifer , Schiller, Gary J. , Roback, John D. , Malynn, Elizabeth, Jackups, Ronald , Avecilla, Scott T. , Bentow, Stanley, Varrone, Jeanne, Fontaine, Magali , Fenelus, Maly , Jeng, Michael , Spencer, Bryan R , O'Brien, Jennifer J, Roback, John D , Avecilla, Scott T , Benjamin, Richard J , Cohn, Claudia S , Wheeler, Allison P , Nooka, Ajay K. , Spinella, Philip C. , Liles, Darla , Gehrie, Eric A , Spencer, Bryan R. , Johnson, Andrew, Liu, Kathy , Corash, Laurence M

Mayo Clinic

Blood Advances | March 6, 2024 | Volume: 8 | Issue: 9 | Pages: 2290-2299

10.1182/bloodadvances.2023012425 | PMID 38447116 Get It

Abstract Patients treated with antineoplastic therapy often develop thrombocytopenia requiring platelet transfusion, which has potential to exacerbate pulmonary injury. This study tested the hypothesis that amotosalen-UVA pathogen–reduced platelet components (PRPCs) do not potentiate pulmonary dysfunction compared with conventional platelet components (CPCs). A prospective, multicenter, open-label, sequential cohort study evaluated the incidence of treatment-emergent assisted mechanical ventilation initiated for pulmonary dysfunction (TEAMV-PD). The first cohort received CPC. After the CPC cohort, each site enrolled a second cohort transfused with PRPC. Other outcomes included clinically significant pulmonary adverse events (CSPAE) and the incidence of treatment-emergent acute respiratory distress syndrome (TEARDS) diagnosed by blinded expert adjudication. The incidence of TEAMV-PD in all patients (1068 PRPC and 1223 CPC) was less for PRPC (1.7 %) than CPC (3.1%) with a treatment difference of –1.5% (95% confidence interval [CI], –2.7 to –0.2). In patients requiring ≥2 PCs, the incidence of TEAMV-PD was reduced for PRPC recipients compared with CPC recipients (treatment difference, –2.4%; 95% CI, –4.2 to –0.6). CSPAE increased with increasing PC exposure but were not significantly different between the cohorts. For patients receiving ≥2 platelet transfusions, TEARDS occurred in 1.3% PRPC and 2.6% CPC recipients (P = .086). Bayesian analysis demonstrated PRPC may be superior in reducing TEAMV-PD and TEARDS for platelet transfusion recipients compared with CPC recipients, with 99.2% and 88.8% probability, respectively. In this study, PRPC compared with CPC demonstrated high probability of reduced severe pulmonary injury requiring assisted mechanical ventilation in patients with hematology disorders dependent on platelet transfusion. This trial was registered at www.ClinicalTrials.gov as #NCT02549222.
Investigating the 2016 surge in firearm violence in Illinois, USA, through community-based organisations: a qualitative study
Dastoor, Jehannaz Dinyar, Thomas, Arielle , Slocum, John D., Regan, Sheila, Stone, Levon, Richardson, Joesph B, Mason, Maryann , Stey, Anne M. , Lin, Katherine, Stey, Anne , Stone, LeVon, Johnson, Julie K. , Lin, Katherine

Mayo Clinic

Injury Prevention | March 6, 2024 | Volume: 30 | Issue: 6 | Pages: 503-508

10.1136/ip-2023-045075 | PMID 38448213 Get It

Background Illinois experienced a historic firearm violence surge in 2016 with a decline to baseline rates in 2018. This study aimed to understand this 2016 surge through the direct accounts of violence prevention community-based organisations (CBOs) in Illinois. Methods We conducted semistructured interviews with 20 representatives from 13 CBOs from the south and west sides of greater Chicago metropolitan area. Interviews were audio recorded, coded and analysed thematically. Results We identified lack of government-derived infrastructure and systemic poverty as the central themes of Illinois’s 2016 firearm violence surge. Participants highlighted the Illinois Budget Impasse halted funding for violence prevention efforts, leading to 2016’s violence. This occurred in the context of a strained relationship with the criminal justice system, where disengagement from police and mistrust in the justice system led victims and families to seek justice outside of the judicial system. Participants emphasised that systemic poverty and the obliteration of community support structures led to overwhelming desperation, which, in turn, increased risky behaviours perceived as necessary for survival. Participants disproportionately identified that this impacted the young people in their communities. Conclusions Lack of government-derived infrastructure and systemic poverty were the central themes of the 2016 firearm violence surge. The insights gained from the 2016 surge are applicable to understanding both current and future surges. CBOs focused on violence prevention offer insights into the context and conditions fuelling surges in the epidemic of violence.
Clinical outcomes and safety of immune checkpoint inhibitors in patients with solid tumors and paraneoplastic syndromes
Zarif, Talal El , Khalid, Ahmed Bilal, Rahme, Serena, Zhong, Caiwei , Salame, Marita , Freeman, Dory , El‐Am, Edward , Ravishankar, Arjun , Ahmad, Bachar , Nana, Frank Aboubakar , Kaldas, David , Naqash, Abdul Rafeh , LeBoeuf, Nicole R. , Malgeri, Andrea , Gupta, Shruti , Al‐Hader, Ahmad, Sparks, Jeffrey A. , Linnoila, Jenny, McKay, Rana R. , Dilling, Thomas J. , Adib, Elio , Najem, Elie, Kim, So Yeon , Sonpavde, Guru , El Zarif, Talal , Gupta, Shruti , Marron, Thomas , Choueiri, Toni K , Adib, Elio , Kim, So Yeon , Sonpavde, Guru , Sparks, Jeffrey A , Aboubakar Nana, Frank , Naqash, Abdul Rafeh , Nassar, Amin H. , Kwak, Lucia , Farhat, Elias Bou , Sharon, Elad , Cortellini, Alessio , Hamnvik, Ole‐Petter R. , Mouhieddine, Tarek H. , Parikh, Kaushal , Choueiri, Toni K.

Mayo Clinic

Journal for ImmunoTherapy of Cancer | March 5, 2024 | Volume: 12 | Issue: 3 | Pages: e008724

10.1136/jitc-2023-008724 | PMID 38448038 Get It

Background Patients with paraneoplastic syndromes (PNS) are excluded from clinical trials involving immune checkpoint inhibitors (ICIs) due to safety concerns. Moreover, real-world data on efficacy and safety is scarce. Methods In this retrospective study, data were collected on patients with PNS and solid tumors receiving ICI between 2015 and 2022 at nine institutions. Patients were classified into: Cohort 1 (pre-existing PNS before ICI initiation), cohort 2 (PNS during ICI treatment), and cohort 3 (PNS after ICI discontinuation). Patients with metastatic non-small cell lung cancer (NSCLC) (mNSCLC) from cohort 1 were matched to patients who were PNS-free at each institution up to a 1:3 ratio for age, sex, type of ICI, use of concurrent chemotherapy, and number of lines of systemic therapy prior to ICI initiation. Kaplan-Meier method was used to assess overall survival (OS) and time-to-next treatment (TTNT). Results Among 109 patients with PNS treated with ICIs, median age at ICI initiation was 67 years (IQR: 58–74). The most represented cancer type was NSCLC (n=39, 36%). In cohort 1 (n=55), PNS exacerbations occurred in 16 (29%) patients with median time to exacerbation after ICI of 1.1 months (IQR: 0.7–3.3). Exacerbation or de novo PNS prompted temporary/permanent interruption of ICIs in 14 (13%) patients. For cohort 2 (n=16), median time between ICI initiation and de novo PNS was 1.2 months (IQR: 0.4–3.5). Treatment-related adverse events (trAEs) occurred in 43 (39%) patients. Grade ≥3 trAEs occurred in 18 (17%) patients. PNS-directed immunosuppressive therapy was required in 55 (50%) patients. We matched 18 patients with mNSCLC and PNS (cohort 1) to 40 without PNS, treated with ICIs. There was no significant difference in OS or TTNT between patients with mNSCLC with and without PNS, although a trend was seen towards worse outcomes in patients with PNS. TrAEs occurred in 6/18 (33%) and 14/40 (35%), respectively. Grade ≥3 trAEs occurred in 4 (22%) patients with PNS and 7 (18%) patients without PNS. Conclusions Exacerbations of pre-existing PNS occurred in 29% of patients treated with ICIs and both exacerbations and de novo PNS occur early in the ICI course. TrAE from ICIs were similar between patients with and without PNS. Our data suggest that pre-existing PNS should not preclude consideration of ICI therapy although patients may not derive the same clinical benefit compared with patients without PNS.
Patient-Derived Tumor Xenograft Study with CDK4/6 Inhibitor Plus AKT Inhibitor for the Management of Metastatic Castration-Resistant Prostate Cancer
Kase, Adam M. , Trynda, Justyna , Miller, James L. , Miller, Erin , Petit, Joachim L. , Barrett, Michael T. , Zhou, Yumei , Parent, Ephraim E. , Cai, Hancheng , Knight, Joshua A. , Orme, Jacob J. , Durham, William F., Metz, Thomas , Meurice, Nathalie , Edenfield, Brandy , Demirer, Aylin Alasonyalılar , Hickman, Peyton G. , Pawlush, Matthew L. , Wickland, Daniel P. , Tan, Winston , Copland, John A. , Gleba, Justyna , Petit, Joachim L , Orme, Jacob J , Reynolds, Jordan P , Durham, William F , Metz, Thomas M , Meurice, Nathalie , Edenfield, Brandy , Alasonyalilar Demirer, Aylin , Bilgili, Ahmet , Hickman, Peyton G , Pawlush, Matthew L , Marlow, Laura , Wickland, Daniel P , Tan, Winston , Copland, John A , Knight, Joshua A , Parent, Ephraim E , Cai, Hancheng , Reynolds, Jordan , Bilgili, Ahmet , Marlow, Laura A.

Mayo Clinic

Molecular Cancer Therapeutics | March 5, 2024 | Volume: 23 | Issue: 6 | Pages: 823-835

10.1158/1535-7163.mct-23-0296 | PMID 38442920 Get It

Abstract Metastatic castration-resistant prostate cancer (mCRPC) is an aggressive malignancy with poor outcomes. To investigate novel therapeutic strategies, we characterized three new metastatic prostate cancer patient derived-tumor xenograft (PDTX) models and developed 3D spheroids from each to investigate molecular targeted therapy combinations including CDK4/6 inhibitors (CDK4/6i) with AKT inhibitors (ATKi). Metastatic prostate cancer tissue was collected and three PDTX models were established and characterized using whole-exome sequencing. PDTX 3D spheroids were developed from these three PDTXs to show resistance patterns and test novel molecular-targeted therapies. CDK4/6i's were combined with AKTi's to assess synergistic antitumor response to prove our hypothesis that blockade of AKT overcomes drug resistance to CDK4/6i. This combination was evaluated in PDTX three-dimensional (3D) spheroids and in vivo experiments with responses measured by tumor volumes, PSA, and Ga-68 PSMA-11 PET-CT imaging. We demonstrated CDK4/6i's with AKTi's possess synergistic antitumor activity in three mCRPC PDTX models. These models have multiple unique pathogenic and deleterious genomic alterations with resistance to single-agent CDK4/6i's. Despite this, combination therapy with AKTi's was able to overcome resistance mechanisms. The IHC and Western blot analysis confirmed on target effects, whereas tumor volume, serum PSA ELISA, and radionuclide imaging demonstrated response to therapy with statistically significant SUV differences seen with Ga-68 PSMA-11 PET-CT. These preclinical data demonstrating antitumor synergy by overcoming single-agent CDK 4/6i as well as AKTi drug resistance provide the rational for a clinical trial combining a CDK4/6i with an AKTi in patients with mCRPC whose tumor expresses wild-type retinoblastoma 1.
Carotid Artery Disease: Then and Now
Brott, Thomas G. , Roubin, Gary S. , Moore, Wesley S. , Meschia, James F. , Meschia, James F

Mayo Clinic

Stroke: Vascular and Interventional Neurology | March 5, 2024 | Volume: 4 | Issue: 2 | Pages: No page available

10.1161/svin.123.001076 | PMID 42100551 Get It

Reply to Kidd et al., “Inconsistencies within the proposed framework for stabilizing fungal nomenclature risk further confusion”
Walsh, Thomas J. , Ahmed, Sarah , Alastruey‐Izquierdo, Ana , Alexander, Barbara D. , Arendrup, Maiken Cavling , Babady, Esther , Balada-Llasat, Joan-Miquel, Borman, Andrew M. , Colgrove, Robert C. , Cornely, Oliver A. , Fuller, Jeff, Gibas, Connie Fe C., Glasgow, Heather, Groll, Andreas H. , Haase, Gerhard , Hanson, Kimberly E. , Harrington, Amanda, Hayden, Randall T. , Hubka, Vít , Johnson, Kristie, Li, Ruoyu , Lanternier, Fanny , Lee, Francesca , Luethy, Paul M. , Kwon‐Chung, Kyung J., Palavecino, Elizabeth , Pancholi, Preeti , Pappas, Peter G. , Procop, Gary W. , Rhoads, Daniel D. , Riedel, Stefan , Stevens, Bryan S. , Sullivan, Kaede Ota, Vergidis, Paschalis , Roilides, Emmanuel , Seyedmousavi, Amir, Tao, Lili , Vicente, Vânia Aparecida , Vitale, Roxana G. , Wengenack, Nancy L. , Westblade, Lars F. , White, Lewis, Wojewoda, Christina , Babady, N. Esther , Seyedmousavi, Seyedmojtaba , de Hoog, Sybren , Walsh, Thomas J , Alastruey-Izquierdo, A , Arendrup, Maiken Cavling , Borman, Andrew , Groll, Andreas H , Hanson, Kimberly , Hayden, Randall T , Hoenigl, Martin , Kus, Julianne V , Meis, Jacques F , Leal, Sixto M , Lockhart, Shawn R. , Kwon-Chung, Kyung J , Nguyen, M Hong , Palavecino, Elizabeth , Pancholi, Preeti , Rhoads, Daniel D , Riedel, Stefan , Vergidis, Paschalis , Roilides, Emmanuel , Wengenack, Nancy L , Wiederhold, Nathan , White, Lewis , Wojewoda, Christina M , Zhang, Sean X , Cornely, Oliver A , Ahmed, Sarah A , Luethy, Paul , Bai, Feng‐Yan , Chowdhary, Anuradha , Clark, Andrew, Dingle, Tanis C. , Dufresne, Philippe J. , Gangneux, Jean‐Pierre , Gräser, Yvonne , Guillot, Jacques , Hawksworth, David L. , Hoenigl, Martin , Kus, Julianne V. , Lackner, Michaela , Leal, Sixto M. , Martin, Isabella W. , Meyer, Wieland , Ostrosky‐Zeichner, Luis , Redhead, Scott A. , Stevens, Bryan, Wang, Qiming , Wiederhold, Nathan P. , Zhang, Sean X.

Mayo Clinic

Journal of Clinical Microbiology | March 5, 2024 | Volume: 62 | Issue: 4 | Pages: No page available

10.1128/jcm.01625-23 | PMID 38441056 Get It

The Role of Imaging for Gastrointestinal Bleeding: Consensus Recommendations From the American College of Gastroenterology and Society of Abdominal Radiology
Sengupta, Neil , Bruining, David H. , Latorre, Melissa, Leighton, Jonathan A. , Wells, Michael , Guglielmo, Flavius F. , Gee, Michael S. , Yoo, Don C. , Ramalingam, Vijay , Huete, Álvaro , Sokhandon, Farnoosh , Grand, David , Tse, Justin R. , Fidler, Jeff L. , Guglielmo, Flavius F , Kastenberg, David , Brook, Olga R. , Naringrekar, Haresh , Gee, Michael Stanley , Soto, Jorge A. , Park, Seong Ho , Khandelwal, Ashish , Gupta, Avneesh , Allen, Brian C. , Anderson, Mark , Dane, Bari , Fidler, Jeff L.

Mayo Clinic

American Journal of Gastroenterology | March 5, 2024 | Volume: 119 | Issue: 3 | Pages: 438-449

10.14309/ajg.0000000000002631 | PMID 38857483 Get It

Gastrointestinal (GI) bleeding is the most common GI diagnosis leading to hospitalization within the United States. Prompt diagnosis and treatment of GI bleeding is critical to improving patient outcomes and reducing high healthcare utilization and costs. Radiologic techniques including computed tomography angiography, catheter angiography, computed tomography enterography, magnetic resonance enterography, nuclear medicine red blood cell scan, and technetium-99m pertechnetate scintigraphy (Meckel scan) are frequently used to evaluate patients with GI bleeding and are complementary to GI endoscopy. However, multiple management guidelines exist which differ in the recommended utilization of these radiologic examinations. This variability can lead to confusion as to how these tests should be used in the evaluation of GI bleeding. In this document, a panel of experts from the American College of Gastroenterology and Society of Abdominal Radiology provide a review of the radiologic examinations used to evaluate for GI bleeding including nomenclature, technique, performance, advantages, and limitations. A comparison of advantages and limitations relative to endoscopic examinations is also included. Finally, consensus statements and recommendations on technical parameters and utilization of radiologic techniques for GI bleeding are provided.